Cargando…
Glutathione Precursor N-Acetyl-Cysteine Modulates EEG Synchronization in Schizophrenia Patients: A Double-Blind, Randomized, Placebo-Controlled Trial
Glutathione (GSH) dysregulation at the gene, protein, and functional levels has been observed in schizophrenia patients. Together with disease-like anomalies in GSH deficit experimental models, it suggests that such redox dysregulation can play a critical role in altering neural connectivity and syn...
Autores principales: | Carmeli, Cristian, Knyazeva, Maria G., Cuénod, Michel, Do, Kim Q. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3285150/ https://www.ncbi.nlm.nih.gov/pubmed/22383949 http://dx.doi.org/10.1371/journal.pone.0029341 |
Ejemplares similares
-
Dysconnection Topography in Schizophrenia Revealed with State-Space Analysis of EEG
por: Jalili, Mahdi, et al.
Publicado: (2007) -
Maintenance N-acetyl cysteine treatment for bipolar disorder: A double-blind randomized placebo controlled trial
por: Berk, Michael, et al.
Publicado: (2012) -
PT619. A Double-Blind, Placebo-Controlled Trial of N-Acetyl Cysteine in the Treatment of Excoriation Disorder
por: Grant, Jon
Publicado: (2016) -
Targeting the Cysteine Redox Proteome in Parkinson’s Disease: The Role of Glutathione Precursors and Beyond
por: Martinez-Banaclocha, Marcos A.
Publicado: (2023) -
Safety and efficacy of N-acetyl-cysteine for prophylaxis of ventilator-associated pneumonia: a randomized, double blind, placebo-controlled clinical trial
por: Sharafkhah, Mojtaba, et al.
Publicado: (2018)